Full Text
Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis

Abstract

Authors

M Papadimitropoulos C Zerbini C Ramos-Remus P Martinez-Osuna B Zhu CL Gaich EG Garcia LF Golcalves

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×